Best Liver cancer doctors in Israel: TOP 20 doctors

Dr. Pelles Sharon specializes in advanced liver cancer treatments at Sourasky Medical Center, including chemotherapy and targeted therapies. She actively contributes to oncological research, ensuring evidence-based patient care.

• Performs liver resections and chemoembolization for liver cancer
• Expert in targeted therapy and immunotherapy approaches
• Conducts research on patient attitudes toward clinical trials

Prof. Merimsky heads the sarcoma unit at Sourasky Medical Center, bringing deep expertise in liver cancer treatment with 41 years of experience of experience.

• Specialist in soft tissue and bone oncology
• Member of ESMO faculty for sarcoma
• Former Chairman of Oncology at Tel-Aviv University
• Extensive research in tumor immunology

Prof. Arber specializes in preventing and diagnosing GI cancers, not just treating them. He runs the Cancer Prevention Center at Sourasky Medical Center.

• Over 44 years of experience of experience in gastrointestinal oncology
• Published over 300 research papers on GI cancers
• Heads the Cancer Prevention Center at Ichilov
• Fellowship and research experience at a top US hospital
• Member of leading international oncology research societies

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Head of the Oncology Division at Tel Aviv's major Sourasky Medical Center – Prof. Wolf leads a top-level team.

• Specialized in medical oncology and internal medicine at Sheba Medical Center
• Completed a postdoctoral fellowship at UCLA's Cedar-Sinai Medical Center
• Member of major oncology societies, including ASCO and AACR
• Senior lecturer at Tel-Aviv University's Sackler Faculty of Medicine

Dr. Ron Greenberg is a leading abdominal surgeon who performs both open and minimally invasive Whipple procedures for liver cancer.

• Has over 35 years of experience of surgical experience
• Heads the Colorectal Surgery Department at Sourasky Medical Center
• Expert in complex procedures including the Whipple technique

Over 32 years of experience' experience treating liver and gastrointestinal cancers – Dr. Ben-haim specializes in complex surgical oncology at Sourasky Medical Center.

• Expert in Whipple surgery for pancreatic cancer
• Focused exclusively on gastrointestinal oncology
• Performs advanced interventions for liver tumors

One of the best Whipple surgeons in Israel, Dr. Klauzner specializes in complex gastrointestinal and pancreatic procedures. He currently chairs the Surgery Department at Sourasky Medical Center (Ichilov).

• More than 42 years of experience of surgical experience
• Expert in liver, colorectal, and pancreatic cancer surgeries
• His specialization includes the complex Whipple procedure
• Holds a senior leadership role at a major academic medical center

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Alexander Beny leads the Gastrointestinal Malignant Service at Rambam Medical Center, specializing in liver cancer treatment.

• Board-certified oncologist with training in medical and radiation oncology
• Expert in gastrointestinal oncology – heads dedicated cancer clinic
• Trained in modern brachytherapy techniques at ESTRO
• Fluent in English and Hebrew for international patients

Professor Rifaat Safadi specializes in liver disease treatment as head of the liver disease unit at Hadassah Medical Center. His work includes immune modulation of liver fibrosis.

• 38 years of experience of experience in gastroenterology and hepatology
• Interned at Sinai School of Medicine with liver disease expert Professor Scott Friedman
• Recipient of multiple awards for liver fibrosis research
• Author of numerous articles and member of international liver study associations
• Serves on the editorial board of Clinical Science journal

Head of Institute of Oncology since 1994 – Tamar Jablonski-Perec leads cancer care at Hadassah Medical Center with decades of expertise.

• Specializes in liver cancer treatment with international training
• Professor of Oncology at Hebrew University
• Member of multiple international cancer communities
• Awarded prestigious Hadassah Medical School scholarship

Dr. Zalmanova specializes in radiotherapy for liver cancer at Assuta Medical Center, a leading hospital in Israel.

• Focused expertise in radiotherapy treatments
• Works at a top-tier medical facility
• Dedicated to personalized patient care